Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.
Open Access
- 1 December 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 137 (11) , 3469-3474
- https://doi.org/10.4049/jimmunol.137.11.3469
Abstract
The presence of neutrophil chemoattractant material in aqueous extracts of lesional psoriatic scale has been investigated by use of an agarose microdroplet chemokinesis method in combination with ultrafiltration and high-performance liquid chromatography (HPLC). Fractions were also assayed for murine thymocyte co-stimulating activity. Aqueous extracts of psoriatic scale contained significantly greater neutrophil chemokinetic activity than extracts of scale from normal skin. Successive ultrafiltration of extracts showed that the chemokinetic material was 10 to 30 kd. Heat lability and gel filtration HPLC characteristics suggested that the major chemokinetically active material in aqueous extracts of psoriatic scale is different from C5a des arg. Reversed-phase HPLC of 0.1% trifluoroacetic acid/acetonitrile extracts of psoriatic scale revealed two clearly resolved peaks of chemokinetic activity, the major peak consistently containing thymocyte co-stimulating activity. No significant neutrophil chemokinetic activity was seen in fractions after reversed-phase HPLC of scale from normal skin. These findings suggest that a major portion of the neutrophil chemoattractant activity in aqueous extracts of psoriatic scale is due to interleukin 1-like material, which may play a role in the pathogenesis of this disease.This publication has 14 references indexed in Scilit:
- The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with PsoriasisJournal of Investigative Dermatology, 1984
- Epidermal T lymphocytes and HLA-DR expression in psoriasisBritish Journal of Dermatology, 1984
- Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.The Journal of Immunology, 1984
- The identification of hydroxy fatty acids in psoriatic skinProstaglandins, 1983
- Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.The Journal of Immunology, 1983
- Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.The Journal of Immunology, 1982
- Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cellsArchives of Dermatological Research, 1982
- Earliest Clinical and Histological Changes in PsoriasisDermatology, 1981
- Characterization of Mononuclear Cell Infiltrates in Psoriatic LesionsJournal of Investigative Dermatology, 1978
- Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.Journal of Biological Chemistry, 1978